Skip to main content

The Trial

The Trial

The MODULATE Trial closed in early 2023.

In 2021, MODULATE relaunched as a remote trial – allowing participants to take part using remote and/or electronic consent, provide fingerprick blood and stool samples at home through the use of an central lab, study medications can be posted directly to participants at home and all study appointments can take place over the phone or using video calling software. The study closed in early 2023. Please contact the study team at modulate@leeds.ac.uk with any queries.